Dr. Oscar Gerardo Arrieta Rodríguez – Oncologist at Médica Sur

Dr. Oscar Gerardo Arrieta Rodríguez is an oncology specialist practicing at Médica Sur in Mexico City. According to the hospital's current medical directory, his specialty is Oncology and his principal area of interest is lung cancer. He sees patients through the Centro Oncológico at Médica Sur.

Lung cancer is a complex disease that can require coordinated evaluation involving imaging, pathology, molecular testing, medical oncology, radiation oncology, surgery, and supportive care. The appropriate treatment pathway depends on the specific type and stage of cancer, the patient's overall health, and the results of diagnostic investigations.

Oncology and Lung Cancer Care

Oncology focuses on the diagnosis and treatment of cancer. Lung cancer care may involve multiple medical disciplines because patients can present with different tumor types, stages, symptoms, and treatment requirements.

A specialist consultation commonly begins with a review of the patient's medical history, symptoms, previous imaging, biopsy or pathology reports, laboratory results, and previous treatments. For patients who have already received treatment elsewhere, bringing complete medical documentation can help the oncology team understand what therapies have previously been administered.

Depending on the diagnosis, cancer treatment may involve surgery, radiation therapy, systemic medications, targeted therapies, immunotherapy, chemotherapy, or combinations of these approaches. Not every treatment is suitable for every patient, and the treatment plan must be individualized.

Practice at Médica Sur

Dr. Arrieta Rodríguez is listed in Médica Sur's official physician directory as an oncologist with a particular interest in lung cancer. The hospital lists his consultation location as the Centro Oncológico, Planta Baja.

Médica Sur's oncology directory includes a broad group of oncology specialists, reflecting the multidisciplinary nature of cancer treatment at the institution.

Importance of Specialized Cancer Evaluation

Patients with suspected or confirmed lung cancer often require detailed diagnostic evaluation. Imaging may help determine the location and extent of disease, while pathology identifies the characteristics of the tumor. In selected cases, additional molecular or biomarker testing can influence treatment selection.

For international patients considering cancer treatment in Mexico, obtaining copies of pathology slides or reports, imaging studies, treatment summaries, medication lists, and laboratory results before traveling can help facilitate a more efficient medical evaluation.

Individualized Treatment Planning

Cancer treatment is not a single standardized process. Treatment decisions may depend on cancer stage, tumor characteristics, previous treatment, age, general health, organ function, and patient preferences.

An oncology specialist can evaluate these factors and explain available treatment options, potential benefits, risks, side effects, and follow-up requirements. Patients should receive a clear explanation of the diagnosis and proposed treatment before making major medical decisions.

International Patient Considerations

Mexico is an important destination for patients seeking private medical care, and Mexico City offers access to hospitals with multiple medical specialties. Patients traveling internationally should confirm the availability of the required oncology service before arranging transportation and accommodation.

Dr. Oscar Gerardo Arrieta Rodríguez is a relevant specialist for patients researching lung cancer and oncology services at Médica Sur. His current specialty and lung-cancer focus are documented in the hospital's physician directory.

Patients should use this profile as general information rather than a substitute for medical advice. Cancer treatment should be determined after an individualized evaluation by a qualified oncology team. Patients should also confirm the doctor's current affiliation, consultation schedule, credentials, and treatment availability directly with Médica Sur.